Stock Runners: Delphi Automotive PLC (NYSE:DLPH), W. P. Carey Inc. (NYSE:WPC), Magellan Petroleum Corporation (NASDAQ:MPET), Novo Nordisk A/S (NYSE:NVO), Biogen Inc. (NASDAQ:BIIB)

Delphi Automotive PLC (NYSE:DLPH) belongs to Consumer Goods sector. Its net profit margin is 7.50% and weekly performance is -7.90%. On last trading day company shares ended up $79.20. Delphi Automotive PLC (NYSE:DLPH) distance from 50-day simple moving average (SMA50) is -8.11%. Delphi Automotive PLC (NYSE:DLPH) has closed the sale of its wholly owned thermal business to MAHLE Behr GmbH & Co. KG and certain of its affiliates, it was announced July 01. Terms of the sale are consistent with those announced on February 19, 2015. At that time, Delphi and MAHLE also signed a separate letter of intent to sell Delphi’s stake in Shanghai Delphi Automotive Air-Conditioning System Co., Ltd., which is expected to close in 2016.

W. P. Carey Inc. (NYSE:WPC) shares moved up 1.08% in last trading session and ended the day at $60.06. WPC Gross Margin is 79.20% and its return on assets is 3.20%. W. P. Carey Inc. (NYSE:WPC) quarterly performance is -8.79%. On July 2, W. P. Carey Inc. (NYSE:WPC), announced that it has acquired a logistics facility in Oskarshamn, Sweden for approximately $26 million (SEK 216 million). The facility was purchased from the developer and is net leased to Scania AB (Scania), a leading manufacturer of commercial vehicles.

On 10 July, Magellan Petroleum Corporation (NASDAQ:MPET) shares fell -1.43% and was closed at $0.34. MPET EPS growth in last 5 year was -6.42%. Magellan Petroleum Corporation (NASDAQ:MPET) year to date (YTD) performance is -62.09%. Magellan Petroleum Corporation (NASDAQ:MPET) announced that it will effect a 1-for-8 reverse stock split of its common stock. At a special meeting of the Company’s stockholders held earlier today, the stockholders approved an amendment to the Company’s certificate of incorporation to effect the reverse stock split at a ratio determined by the Company’s Board of Directors within a ratio of not less than 1-for-3 and not greater than 1-for-10.

Novo Nordisk A/S (NYSE:NVO) ended the last trading day at $57.68. Company weekly volatility is calculated as 1.24% and price to cash ratio as 109.46. Novo Nordisk A/S (NYSE:NVO) showed a weekly performance of 4.53%. Denmark’s Novo Nordisk A/S (NYSE:NVO) said on Friday its new once-weekly diabetes drug semaglutide worked successfully in a late-stage clinical trial, boosting hopes for a medicine seen as critical to maintaining the firm’s lead in the field. In the Phase IIIa trial, patients with a baseline HbA1c reading of 8.1 percent injected with 0.5 mg and 1.0 mg of semaglutide showed improvements of 1.5 percent and 1.6 percent, respectively, compared with no change in those on placebo.

Biogen Inc. (NASDAQ:BIIB) shares fell -2.77% in last trading session and ended the day at $388.23. BIIB Gross Margin is 88.10% and its return on assets is 23.30%. Biogen Inc. (NASDAQ:BIIB) quarterly performance is -8.79%. One of Biogen Inc. (NASDAQ:BIIB)’s top executives has announced that he will leave at the end of the month to become the CEO of an unnamed startup. Douglas Williams has acted as Biogen’s (Nasdaq: BIIB) executive vice president of research and development at the Cambridge-based biotech since 2011 after rolls at Fred Hutchinson Cancer Research Center, ZymoGenetics, Seattle Genetics Inc., Amgen Inc., and Basic Research, according to Biogen’s website.

Leave a Reply

Your email address will not be published. Required fields are marked *